Jounce Therapeutics, Inc.

BAILARD, INC.

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/8/2023

Shares

90,200

Value ($000)

167

Weight

0.0%

2019 Q4 - 2023 Q1 (10 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/8/2023	167	0.0%	90,200	3/31/2023
2021 Q4	2/10/2022	267	0.0%	31,952	12/31/2021
2021 Q3	11/15/2021	237	0.0%	31,952	9/30/2021
2021 Q2	8/13/2021	217	0.0%	31,952	6/30/2021
2021 Q1	5/13/2021	170	0.0%	16,552	3/31/2021
2020 Q4	2/3/2021	109	0.0%	15,552	12/31/2020
2020 Q3	11/10/2020	120	0.0%	14,652	9/30/2020
2020 Q2	8/12/2020	101	0.0%	14,652	6/30/2020
2020 Q1	4/16/2020	70	0.0%	14,652	3/31/2020
2019 Q4	1/31/2020	128	0.0%	14,652	12/31/2019